Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Medicaid spending on drugs has gone up 50% per patient from 2008 to 2016. Photo: Shawn Patrick Ouellette/Portland Press Herald via Getty Images
Pharmaceutical companies attempt to maximize their Medicaid sales by luring doctors with consulting fees and dinners, and by paying speakers to testify positively about their drugs, according to an investigation from The Center for Public Integrity and NPR.
Go deeper: Read the story, which outlines how one doctor in Arizona who promoted schizophrenia drugs received $700,000 from the industry.